Alcami Corporation and the University of North Carolina Wilmington Announce Academic Partnership

[STK]

[IN] HEA MTC PHA BIO

[SU] JVN

— WITH PHOTO — TO BUSINESS, HEALTH, AND MEDICAL EDITORS:

Alcami Corporation and the University of North Carolina Wilmington

Announce Academic Partnership

WILMINGTON, N.C., July 26, 2017 /PRNewswire/ — Alcami Corporation, a

leading provider of custom development and manufacturing services for

the pharmaceutical and biotechnology industries, today announced an

academic partnership with the University of North Carolina Wilmington

(UNCW). Since July 2016, the university and privately held pharma and

biotechnology company have collaborated to develop two courses

designed to enhance workforce education and prepare students for a

career in pharmaceutical sciences.

Beginning in the spring of 2017, UNCW students had the opportunity to

take an elective course co-taught by the Alcami team, “Pharmaceutical

Drug Development and Good Manufacturing Practices (GMP) of Medicinal

Products for Human and Veterinary Use.” A group of full-time Alcami

employees from various functional areas, such as manufacturing,

packaging, quality and laboratory operations, team-taught the

lecture-based course. This course was designed to provide students

with an overview of the drug development process from concept to

commercialization, focusing specifically on current good manufacturing

practices (cGMP). At the same time, students were introduced to

available career opportunities and prepared for initiating a career in

science, business or other roles within the pharmaceutical industry or

related medical fields.

“This type of collaborative program is a first for Alcami, and we are

excited and encouraged about the high level of interest and positive

feedback that we have received,” says Dr. Stephan Kutzer, Ph.D.,

Alcami President and CEO. “We are committed to building and

maintaining strong relationships within the communities in which we

operate, and with such a highly regarded university in our own

backyard, we are privileged to have the opportunity to share our

expertise with the university’s students. We look forward to

continuing this partnership this upcoming fall.”

A second laboratory-based course will be taught this fall at UNCW’s

state-of-the-art marine biology center (MARBIONC). The Alcami GMP

Training Lab will facilitate this course offering by focusing on the

application of cGMPs in a drug development and testing laboratory.

“We are excited to have Alcami as one of the primary tenants in the

MARBIONC building,” said Dr. Ron Vetter, UNCW’s Associate Provost for

Research and Dean of the Graduate School. “These private and public

partnerships that focus on biotechnology, analytical sciences, and

pharmaceutical research and development are just the kind of

activities we envisioned for the facility when it was built.”

UNCW and Alcami continue to discuss ways to grow and expand the

relationship, including adding more internship opportunities for

students, exploring collaborative research projects, and establishing

innovative platform technologies for the development and manufacturing

of Biologics. Alcami has over 20 years of experience in biotherapeutic

analytical development to share with UNCW students. Alcami scientists

are equipped with the technology and armed with the expertise to

support a wide variety of biotherapeutic products, including peptides,

proteins, antibodies, antibody drug conjugates (ADC), and cell and

gene therapies.

ABOUT ALCAMI

Alcami is a world-class contract development and manufacturing

organization (CDMO) with executive offices in Wilmington and Durham,

North Carolina. With over 1,000 employees operating at seven sites

globally, Alcami provides customizable and innovative services to

small and mid-size pharmaceutical and biotechnology companies by

offering individualized and integrated services across multiple areas.

We connect our clients with innovative solutions for API development

and manufacturing, solid-state chemistry, formulation development,

analytical development and testing services, clinical and commercial

finished dosage form manufacturing (oral solid dose and parenteral),

packaging, and stability services. For more information, please visit

www.alcaminow.com.

ABOUT UNIVERSITY OF NORTH CAROLINA WILMINGTON

The University of North Carolina Wilmington, the state’s coastal

university, is dedicated to learning through the integration of

teaching and mentoring with research and service. Guided by our

Strategic Plan, the university is committed to nurturing a campus

culture that reflects its values of diversity and globalization,

ethics and integrity, and excellence and innovation. A public

institution with nearly 16,000 students, the university is focused on

supporting and enhancing the student-centered learning experience that

has been a hallmark since its founding in 1947. UNCW offers an array

of programs at the baccalaureate and master’s levels, and doctoral

programs in marine biology, educational leadership, psychology and

nursing practice.

CONTACT: CONTACT ALCAMI, Catherine Hanley, Sr. Director, Marketing &

Corporate Communications, +1 910.254.7273,

catherine.hanley@alcaminow.com, www.alcaminow.com, CONTACT UNIVERSITY

OF NORTH CAROLINA WILMINGTON, Media contact: CHRISTINA SCHECHTMAN,

OFFICE OF UNIVERSITY RELATIONS, schechtmanc@uncw.edu / 910.962-3080

View original content with

multimedia:http://www.prnewswire.com/news-releases/alcami-corporation-and-the-university-of-north-carolina-wilmington-announce-academic-partnership-300494543.html

SOURCE Alcami Corporation

-0- 07/26/2017

/Photo: https://mma.prnewswire.com/media/344471/Alcami_Logo.jpg

/Web Site: http://www.alcaminow.com

CO: Alcami Corporation; University of North Carolina Wilmington

ST: North Carolina

IN: HEA MTC PHA BIO

SU: JVN

PRN

— CL51232 —

0000 07/26/2017 15:00:00 EDT http://www.prnewswire.com